Eone Diagnomics Genome Center (EDGC) said Wednesday that its affiliate test kit maker, Solgent, has been registered as the first Korean company for stockpile procurement by the U.S. Federal Emergency Management Agency (FEMA).
Solgent will initially export the new coronavirus test kits for 150,000 people and 40 other diagnostic kits, including the Middle East Respiratory Syndrome, as a procurement supplier for the U.S. government.
On top of that, Solgent submitted for the official approval for permanent use in the U.S., besides the emergency use approval from the Food and Drug Administration for its COVID-19 diagnostic kit developed until March 22.
"Our becoming the first test kit maker to supply to FEMA is a reaffirmation of the excellence and reliability of Korea's molecular diagnosis technology worldwide in the battle against the COVID-19 virus," Solgent CEO Yoo Jae-hyung said.
The company plans to promote supplying COVID-19 test kit procurements for FEMA, and also to provide stable supplies of its test kit, DiaPlexQ, for 51 U.S. state governments, including the Washington D.C.
Solgent's DiaplexQ is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus.
Solgent began to export diagnostic kits to test 100,000 people to Ukraine on March 27 at the request of Ukrainian President Vladimir Zelensky.
<© Korea Biomedical Review, All rights reserved.>